Remove Contracts Remove Invention Remove Public Use Remove Reference
article thumbnail

Spilling Secrets to AI: Does Chatting with ChatGPT Unleash Trade Secret or Invention Disclosure Dilemmas?

Trading Secrets

API access data policy is different, stating that customer data is not used for training/tuning the model, but is kept for up to 30 days for abuse and misuse monitoring. API access refers to access via ChatGPT’s API, which developers can integrate into their applications, websites, or services. enablement).

article thumbnail

Spilling Secrets to AI: Does Chatting with ChatGPT Unleash Trade Secret or Invention Disclosure Dilemmas?

LexBlog IP

API access data policy is different, stating that customer data is not used for training/tuning the model, but is kept for up to 30 days for abuse and misuse monitoring. API access refers to access via ChatGPT’s API, which developers can integrate into their applications, websites, or services. enablement).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Spilling Secrets to AI: Does Chatting with ChatGPT Unleash Trade Secret or Invention Disclosure Dilemmas?

LexBlog IP

API access data policy is different, stating that customer data is not used for training/tuning the model, but is kept for up to 30 days for abuse and misuse monitoring. API access refers to access via ChatGPT’s API, which developers can integrate into their applications, websites, or services. enablement).

article thumbnail

Biosimilars 2020 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

None of these was the first biosimilar for its respective reference product. Note that FDA still has not designated any biosimilar as interchangeable to its reference product. FDA has approved 29 biosimilars corresponding to nine different reference products. Reference Product. Reference Product. Biosimilar Drug.